1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer : results from a population-based cohort
2024) In Breast Cancer Research and Treatment(
- Contribution to journal › Article
- 2023
-
Mark
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
(
- Contribution to journal › Article
- 2021
-
Mark
Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
(
- Contribution to journal › Article
- 2018
-
Mark
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
(
- Contribution to journal › Article
- 2017
-
Mark
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
(
- Contribution to journal › Article
-
Mark
Inflammatory Cells and Mediators in the Tumor Microenvironment of Breast Cancer
2017)(
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer
(
- Contribution to journal › Article